Elio Adib
Impact in
- Communication top 5%
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
Papers in
- Oncology 14
- Cancer Immunotherapy and Biomarkers 11
-
- Renal cell carcinoma treatment 6
- Lung Cancer Treatments and Mutations 5
- Co-authors
- Amin H. Nassar (16 shared papers)David J. Kwiatkowski (11 shared papers)Basil S. Karam (1 shared paper)Joseph Abi Jaoude (1 shared paper)Jabra G. Zarka (1 shared paper)Cindy Traboulsi (1 shared paper)Molly Blue El Alam (1 shared paper)Afif M. Kraitem (1 shared paper)
- Journals
- Cancer Cell (4 papers)JAMA Oncology (3 papers)Clinical Genitourinary Cancer (3 papers)JCO Precision Oncology (3 papers)Journal of Thoracic Oncology (3 papers)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Elio Adib
42 papers receiving 1.8k citations
Elio Adib's Hit Papers
Peers
Comparison fields: 5 of 110
- Communication 137
- Oncology 460
- Health 118
- Cancer Research 155
- Pulmonary and Respiratory Medicine 316
Countries citing papers authored by Elio Adib
This map shows the geographic impact of Elio Adib's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elio Adib with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elio Adib more than expected).
Fields of papers citing papers by Elio Adib
This network shows the impact of papers produced by Elio Adib. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elio Adib. The network helps show where Elio Adib may publish in the future.
Co-authors
The 25 scholars most cited alongside Elio Adib, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Coronavirus Goes Viral: Quantifying the COVID-19 Misinformation Epidemic on Twitter Hit paper breakdown → | 2020 | 653 |
| 2 | 2021 | 162 | |
| 3 | 2022 | 106 | |
| 4 | 2021 | 86 | |
| 5 | 2022 | 84 | |
| 6 | 2022 | 83 | |
| 7 | 2022 | 53 | |
| 8 | 2024 | 52 | |
| 9 | 2023 | 50 | |
| 10 | 2023 | 45 | |
| 11 | 2021 | 44 | |
| 12 | 2023 | 43 | |
| 13 | 2021 | 39 | |
| 14 | 2021 | 27 | |
| 15 | 2022 | 27 | |
| 16 | 2024 | 27 | |
| 17 | 2021 | 25 | |
| 18 | 2023 | 23 | |
| 19 | 2021 | 21 | |
| 20 | 2022 | 20 |
About Elio Adib
Elio Adib is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 45 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Renal cell carcinoma treatment (6 papers), Cancer Genomics and Diagnostics (5 papers), Lung Cancer Treatments and Mutations (5 papers), Epigenetics and DNA Methylation (4 papers), Bladder and Urothelial Cancer Treatments (4 papers), Genetic factors in colorectal cancer (3 papers) and Renal and related cancers (3 papers). The work is most often cited by research in Communication (137 citations), Oncology (460 citations), Health (118 citations), Cancer Research (155 citations) and Pulmonary and Respiratory Medicine (316 citations). Elio Adib has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Amin H. Nassar, David J. Kwiatkowski, Basil S. Karam, Joseph Abi Jaoude, Jabra G. Zarka, Cindy Traboulsi, Molly Blue El Alam, Afif M. Kraitem, Ramez Kouzy and Khalil Baddour. Their work appears in journals such as Cancer Cell, JAMA Oncology, Clinical Genitourinary Cancer, JCO Precision Oncology and Journal of Thoracic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.